Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed Jan 7, 2020
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-01-03−3,851→ 100,153 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018 and March 1, 2019.
- [F2]The shares were sold at a range of prices between $19.75 and $19.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.